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Summary
Background: Management of patients with aortic
stenosis is challenging since only few data exists indi-
cating the rate of progression and the correlation to rel-
evant determinants. We investigated whether analysis
of the long-term progression, etiology and vascular risk
factors could help to define optimal control intervals.
Methods:We included 77 patients (age 51.1 ± 14.3
years) in one referral centre with an echocardiography-
proven aortic stenosis (mean gradient >12 mmHg) and
a long-term follow-up of three echocardiographic ex-
aminations. Missing clinical data were supplemented
by a questionnaire to the general practitioner. Two ret-
rospective examination time intervals were defined as
a second interval of <2 years (1.3 ± 0.4) and a first in-
terval of >2 years (6.0 ± 2.4) dating back to the initial
examination (maximum of 10.6 years prior to the last
examination).
Results: During 6.0 ± 2.4 years, the mean pressure
gradient increased from 24.2 ± 13.6 to 38.1 ± 20.4 mm
Hg (p <0.0001); respectively 2.1 ± 3.0 mm Hg/year in
the first time period and 4.2 ± 8.2 mm Hg/year in the
second time period (p = 0.049), for the entire popula-
tion. According to severity, patients with mild or mod-
erate aortic stenosis showed an increase from 2.0 ± 2.7
to 4.0 ± 6.6 mm Hg/year (p = 0.04) or from 2.2 ± 3.2 to
3.5 ± 10.9 mm Hg/year respectively (p = 0.66). The
group with severe aortic stenosis had an increase of 9.6
± 12.0 mm Hg/year (group too small for statistical
analysis).
During the total examination period, left ventricu-





(p <0.0001), which corresponds to an increase
of 3.2 to 7.8 g/m
2
per annum (p = 0.52), and the relative
wall thickness increased from 40.0 ± 8.5 to 43.0 ± 9.8%
(p = 0.002). Ejection fraction remained stable and we
found no correlation between etiology, vascular risk fac-
tors and progression of the disease.
Conclusions: Progression of the mean pressure gra-
dient in patients with aortic stenosis went from 2 mm
Hg/year for mild stenosis, to 4 mm Hg/year for moder-
ate stenosis. We found no correla-
tion to conventional vascular risk
factors. In patients with mild aortic
stenosis and preserved left ventric-
ular ejection fraction, echocardiographic follow-up
every 3 to 5 years, until a mean transvalvular pressure
gradient of 30 mm Hg is reached, might be a safe and
cost-effective follow-up strategy. In patients with more
severe aortic stenosis, follow-up has to be more fre-
quent.
Introduction
The most frequent cause of aortic stenosis is the de-
generation of the aortic valve, which leads from an aor-
tic sclerosis to an aortic stenosis (AS) in one out of six
patients [1]. Although there is a lot of evidence avail-
able regarding the natural history and progression of
AS, the data concerning the development of the pres-
sure gradient over time are inconsistent. Potential risk
factors are still in debate and there is a discussion
about clinical and genetic factors, and cellular and mo-
lecular reactions due to early inflammatory lesions [14,
15]. Therefore progression seems not to be simply a
consequence of atherosclerosis and degeneration of the
aortic valve, but also to be influenced by mechanical
stress and various other factors. Better knowledge of
potential risk factors and rate of pressure rise should
be helpful when searching for an effective therapy to
avoid calcification of the aortic valve. The aim of this
study was to analyse the long-term progression of AS in
relation to the etiology, as well as to co-existing vascu-
lar risk factors, and to investigate the rate of progres-




220 patients were eligible for inclusion into our study based
on the leading diagnosis of an AS, after checking the clinical
database of the echocardiography laboratory at the Hospital
of the University of Zurich. 74 patients had to be excluded be-
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cause of incomplete echocardiographic examinations and 69
due to incomplete follow-up data. Thus, 77 patients were in-
cluded in the study. Only patients with an echocardiography-
proven aortic stenosis (mean pressure gradient [Pmean] of at
least 12 mm Hg) and a long-term follow-up of at least three
echocardiographic examinations were included. Patients with
severe aortic regurgitation were excluded. The progression of
aortic stenosis was analysed in relation to different determi-
nants, such as gender, etiology (congenital, postrheumatic,
degenerative), severity, obesity, vascular risk factors (hyper-
tension, history of smoking, diabetes mellitus) and intake of
statines or ACE inhibitors.
Follow-up protocol
The echocardiographic examinations were analysed retro-
spectively. Based on the last examination of native valve, two
retrospective time intervals were defined: a second interval
from 0.25–2 years (1.3 ± 0.4 years) and a first interval from
2 years dating back to the first and oldest echocardiographic
examination (6.0 ± 2.4 years up to a maximum of 10.6 years).
Clinical data were collected from the clinical database and
completed by a questionnaire sent out to general practition-
ers (rate of return 77%).
Echocardiography
The severity of the aortic stenosis was classified according to
the guidelines of the European Society of Cardiology [18].
Thus severity of aortic stenosis was classified upon mean
pressure gradient measurements of mild (Pmean <30 mm
Hg), moderate (Pmean 30–50 mmHg) and severe (Pmean >50
mm Hg).
Measurements of the left ventricular mass index (LVMI), left
ventricular ejection fraction (LVEF), relative wall thickness
(RWT) and fractional shortening (FS) were performed ac-
cording to the guidelines of the American Society of Echocar-
diography [19].
Furthermore, development of left ventricular (LV) mass in-
dexed to body surface area (LVMI), RWT, LVEF as well as FS
of the left ventricle were analysed. Changes of Pmean and
LVMI over time between the two examinations were divided
by the time period (delta Pmean respectively delta LVMI).
Statistical analysis
For statistical analysis, the programme StatView (SAS Insti-
tute Inc., San Francisco, CA, USA) was used. The numerical
data was shown as mean with standard deviation and the cat-
egorical variables as percentage. For the comparison within
one group, a paired t-test and between different groups an
unpaired t-test were applied. Comparisons of groups was ac-
complished by ANOVA or a chi-square test. The limit for sig-
nificance was defined as p-value below 0.05.
Results
At the time of the first examination, the mean age of
the 77 included patients was 51.1 ± 14.3 years (ranging
from 24.4 to 77.9 years). Baseline characteristics are
given in table 1. Classification according to the etiol-
ogy only showed a younger age in patients with con-
genital AS than in the other groups (44.0 ± 13.7 vs 55.7
± 12.9 years (p = 0.0003).
Pressure gradient
For the entire population during the study period,
Pmean increased from 24.2 ± 13.6 to 38.1 ± 20.4 mm
Hg (p <0.0001). Progression showed an increase of 2.1
± 3.0 mm Hg/year in the first time period and 4.2 ± 8.2
mm Hg/year in the second time period (p = 0.0499).
In patients with a mild aortic stenosis at baseline,
we found an increase of Pmean from 16.9 ± 5.8 mm Hg
to 31.3 ± 17.8 mm Hg (p <0.0001), whereas in those
with a moderate or severe stenosis at baseline, the
mean pressure gradient increased from 35.2 ± 3.4 mm
Hg to 48.1 ± 10 mmHg (p <0.0001) and from 63.3 ± 10.9
to 80.8 ± 20.3 mm Hg (p = 0.14), respectively.
According to the severity of AS, delta Pmean in-
creased from 2.0 ± 2.7 to 4.0 ± 6.6 mm Hg/year (p =
0.04) in mild AS, and from 2.2 ± 3.2 to 3.5 ± 10.9 mm
Hg/year (p = 0.66) in moderate AS.
Left ventricular mass index and
function
For the whole study population,
LVMI increased from 149 ± 60 g/m
2
to 168 ± 63 g/m
2
(p <0.0001) with an
increase of delta LVMI from 3.2 ±
9.9 g/m
2
/year to 7.8 ± 40.7 g/m
2
/year
(p = 0.52) between the first and the
second time period.
In patients with mildAS, LVMI





(p = 0.002) and in pa-
tients with moderate stenosis from
150 ± 54 g/m
2




During examination, RWT in-
creased from 40.0 ± 8.5% to 43.0 ±
9.8% (p = 0.002) for the entire pop-
ulation. Classification according to
the severity of AS showed an in-
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Table 1
Baseline characteristics of patients with aortic stenosis.
All Mild AS Moderate AS Severe AS
(n = 77) (n = 54) (n = 19) (n = 4)
Mean age (years) 51.1 53.5 47.4 36.3
Women (%) 36 39 32 25
Etiology of AS (%)
Degenerative/postrheumatic 61 68 42 50
Congenital 39 32 58 50
Arterial Hypertension (%) 36 40 29 25
Diabetes mellitus (%) 7 6 0 50
Hypercholesteremia (%) 45 40 63 25
History of smoking (%) 39 34 50 50
Obesity (%) 10 9 16 0
ACE-Inhibitors (%) 45 47 44 33
Statins (%) 29 26 47 0
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crease of RWT from 38.5 ± 8.1% to 42.0 ± 9.9% (p =
0.01) for mild, from 42.6 ± 8.9% to 43.9 ± 8.8% (p = 0.09)
for moderate and from 48.0 ± 5.3% to 52.9 ± 9.3% (p =
0.27) for severe AS.
During follow-up, LVEF did not change signifi-
cantly in the entire population or in the different
groups (table 2–4).
Further classifications
Categorisation of gender, history of smoking, hyper-
tension, hyperlipidemia, obesity, intake of ACE in-
hibitors or statines did not show any correlation for
progression of the aortic mean pressure gradient. The
influence of diabetes mellitus could not be evaluated
(only 4 patients). Patients with a history of smoking or
hyperlipidemia were significantly younger (44.0 ± 11.9
vs 56.8 ± 13.1 years (p = 0.0001) and 45.9 ± 13.1 vs 58.4
± 11.9 years (p <0.0001), respectively at study entry,
which had no impact on the progression of AS.
Discussion
Although there is a lot of evidence available regarding
the natural history and progression of AS, the data con-
cerning the development of the mean as well as the
maximal pressure gradient over time are inconsistent.
We could establish a nonlinear progression of delta
Pmean in AS, accelerating from 2 mm Hg/year during
the first study interval to 4 mm Hg/year during a later
study interval. In patients with severe stenosis, we
found a steeper increase of 9 mm Hg/year, but we did
no further analysis. However our results imply a non-
linear increase of Pmean, which contrasts to other
studies [3–5] describing a linear increase of delta
Pmean between 5 and 9 mm Hg/year. Although only
Doppler flow velocity and ejection fraction were inde-
pendent predictors of subsequent cardiac events from
all clinical and echocardiographic variables in the
study of Pellikka et al. [6], we found no significant dif-
Cardiovascular Medicine 2010;13(6):204–207
Table 2
Results for all patients (77 patients).
Age Pmean LVMI RWT LVEF FS
(year) (mm Hg) (g/m
2
) (%) (%) (%)
Exam 1 51.1 ± 14.3 24.2 ± 13.6 149 ± 60 40.0 ± 8.5 75.7 ± 9.0 38.4 ± 7.3




Exam 2 2 55.9 ± 14.4 32.3 ± 16.8 163 ± 60 42.9 ± 9.5 74.6 ± 9.9 37.7 ± 8.0




Exam 3 57.2 ± 14.4 38.1 ± 20.4 168 ± 63 43.0 ± 9.8 73.5 ± 12.7 37.3 ± 10.1
Pmean = mean pressure gradient; LVMI = left ventricular mass index; RWT = relative








Results for all patients with mild aortic stenosis (54 patients).
Age Pmean LVMI RWT LVEF FS
(year) (mm Hg) (g/m
2
) (%) (%) (%)
Exam 1 53.5 ± 13.4 16.9 ± 5.8 142 ± 55 38.5 ± 8.1 74.3 ± 9.7 37.3 ± 7.6
Δ/Δt 2.0 ± 2.7 1.6 ± 8.2
Exam 2 58.6 ± 13.5 25.5 ± 13.5 155 ± 51 41.4 ± 9.9 73.1 ± 10.6 36.5 ± 8.3
Δ/Δt 4.0 ± 6.6 10.4 ± 42.8
Exam 3 59.9 ± 13.5 31.3 ± 17.8 161 ± 56 42.0 ± 9.9 73.8 ± 13.9 37.9 ± 11.1
Table 4
Results for all patients with moderate aortic stenosis (19 patients).
Age Pmean LVMI RWT LVEF FS
(year) (mm Hg) (g/m
2
) (%) (%) (%)
Exam1 47.4 ± 15.1 35.2 ± 3.4 150 ± 54 42.6 ± 8.9 79.2 ± 6.4 41.4 ± 6.2
Δ/Δt 2.2 ± 3.2 5.4 ± 12.9
Exam 2 51.6 ± 14.5 44.1 ± 9.3 168 ± 56 46.2 ± 8.1 78.3 ± 7.1 40.6 ± 6.8
Δ/Δt 3.5 ± 10.9 –3.6 ± 33.8
Exam 3 52.7 ± 14.6 48.1 ± 10.0 165 ± 58 43.9 ± 8.8 72.4 ± 10.4 35.8 ± 8.2
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ferences or factors influencing LVEF or FS, but a sig-
nificant increase of LVMI for mild AS and a trend for
moderate AS (p = 0.053).
Influence of the etiology on the progression
of aortic stenosis
In our study classification according to the etiology of
AS, we found significant differences only for age. As ex-
pected, patients with congenital AS were significantly
younger. In accordance to other studies, although some
were very small, we could find no significant differ-
ences between the group of degenerative and
postrheumatic etiology nor an impact of the etiology on
the progression of AS [3, 5, 7, 8]. Therefore we com-
bined them as one group for further analysis. However
we found no results supporting that the etiology has
any impact on the natural history of AS.
Influence of severity on the progression
of aortic stenosis
The current study showed that prediction of the pro-
gression of the pressure gradient should rely on the
severity of stenosis at baseline. This is consistent to the
study of Otto et al. [3] who concluded that the degree of
severity at baseline is the strongest predictor for the
progression of AS, but other studies [5, 6, 9] found no
significant influence.
Other factors
In our study, neither a correlation of pressure increase
to vascular risk factors nor a positive effect of the in-
take of ACE inhibitors or statins on the progression of
AS could be detected [2–8]. Davies et al. [5] found a cor-
relation of both the age of the patient and the degree of
calcification with progression of the pressure gradient.
However, this was not examined in our study be-
cause quantification of calcification based on morpho-
logical criteria alone is inaccurate.
Limitations of this study
Of the 146 patient included in our study, 69 had to be
excluded due to missing data. Therefore some groups
were too small for statistical analysis. However, pro-
gression of aortic stenosis could be evaluated for the
most important confounding factors. Unfortunately we
could only include four patients with severe aortic ste-
nosis.
Conclusions
In patients with aortic stenosis, the progression of
mean pressure gradient was 2 mm Hg/year for mild
stenosis to 4 mm Hg/year for moderate stenosis. We
found no correlation to conventional vascular risk fac-
tors. In patients with mild aortic stenosis and pre-
served left ventricular ejection fraction, echocardio-
graphic follow-up every 3 to 5 years until a mean trans-
valvular pressure gradient of 30 mm Hg is reached
might be a safe and cost-effective follow-up strategy. In
patients with more severe aortic stenosis, follow-up has
to be more frequent.
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